Ending the HIV Epidemic: The Role of Provider Advocacy

Similar documents
The HIV Medicine Association (HIVMA) of the Infectious Diseases Society of America (IDSA)

The National Infrastructure for Hepatitis C: Is There Anyone Home? December 21, 2015

The Affordable Care Act and Viral Hepatitis: Opportunities and Challenges

Leading for Impact. $8.5 million through 215 grants. $4.5 million highlights:

Health Department Role: Eliminating HBV and HCV

What are the goals of the NJHPG?

TAG TEAM TOGETHER EVERYONE ACHEIVES MORE

Strategies to Improve Viral Hepatitis Prevention, Care and Treatment through Appropriations. Emily McCloskey USCA October 3, 2014

ADVOCATING FOR PATIENTS WITH DIABETES

THE AFFORDABLE CARE ACT, MEDICAID & RYAN WHITE: THE HIV VOTE. Daniel Tietz, RN, JD Executive Director

US Proposal to Transform Response to Hepatitis B and C. Anna S. F. Lok, MD University of Michigan Ann Arbor, MI, USA

FY2018 Labor, Health and Human Services, Education Appropriations Summary

HIV/HCV Co-Infection: Challenges and Opportunities on the Path to Elimination

HIV Testing Reimbursement Subcommittee of the HIV Health Care Access Working Group (Affiliated with the Federal AIDS Policy Partnership)

FY2019 Labor, Health and Human Services, Education Appropriations Summary

Impact of Sequestration on People Living with HIV/AIDS

Oral Health Provisions in Recent Health Reform: Opportunities for Public-Private Partnerships

FY2019 Labor, Health and Human Services, Education Appropriations Summary

HEALTH ADVOCACY: THE KEY TO OUR FUTURE

The Role of Liver Societies in the Global Viral Hepatitis Response

March XX, Washington, DC Washington, DC Washington, DC Washington, DC 20515

Goals and Objectives

Hep B United National Summit Report July 27-29, 2016 Washington, D.C.

8 Policy Recommendations for Improving the Health & Wellness of Older Adults with HIV

Meeting with Your Congressional Delegation at Home

Eliminating Hepatitis C in the United States Treatment Access for All! Ryan Clary Executive Director December 7, 2016

What are the goals of the NJHPG?

Infectious Disease The Public Health Response

NASTAD AT-A-GLANCE. Britten Pund, Director, Health Care Access

Advocacy & Asthma Tools and Tips to get you started

VOLUME 2, 2018 Advocacy: The Critical First Step Lupus Insight Prize Patient Involvement Lupus News Corner ADVOCACY Lupus Awareness Month

Moderator: Panelists:

ABOUT LUNG CANCER ALLIANCE

SUPPORT FUNDING FOR DOMESTIC HIV/AIDS PREVENTION, TREATMENT, AND RESEARCH

Eliminating the Public Health Problem of Hepatitis B and C in the United States. April 10, 2017

The Role of Liver Societies in the Global Viral Hepatitis Response

Integrating Hepatitis Services into HIV Programs: Working Together to Meet Community Needs

Integrating Hepatitis Services into HIV Programs: The Local Health Department Perspective

Heart Disease and Stroke. You re the Cure. You re the Cure A Guide for Advocates

#2015USCA

National Plan to Eliminate Viral Hepatitis

Health Care Reform Update and Advocacy Priorities

AIDS Foundation of Chicago Strategic Vision

National Health Center Week 2016 Kick-Off Webinar. May 11, 2016 Presented by the NACHC Advocacy Team

Legislation and Policy Practice

September 1, The Honorable Tom Price, MD Secretary Department of Health and Human Services 200 Independence Avenue SW Washington, DC 20201

Opioid Overview Admiral Brett P. Giroir, M.D.

California Legislative Ambassador Program

Funding the Ryan White Program: Now and in the Future

DRUG POLICY ALLIANCE. Reason. Compassion. Justice.

AAPD 2018 Legislative and Regulatory Priorities Council on Government Affairs Approved by the Board of Trustees on January 12, 2018

Keys to a Successful Legislative Visit

Effective Advocacy. Creating an advocacy campaign to engage our communities. September 27, 2017 AIFC

The Hidden Bars of the HIV Health Care Continuum: A Fish Bowl Exercise. Martha Cameron The Women s Collective

THE NEW YORK CITY AIDS FUND

Integrated SCSN/Comprehensive Plans and How a Range of Integrated HIV Planning Activities Can Contribute

NIDA Responds to the Syndemic of Opioids, Viral Hepatitis and HIV. Wilson M. Compton, M.D., M.P.E. Deputy Director, National Institute on Drug Abuse

Washington, DC Washington, DC Washington, DC Washington, DC 20510

Advocating for Sensible Policies in the Age of HCV Cure

ENDING THE EPIDEMICS: A NATIONAL, STATE, AND CITY APPROACH

Health Center Advocacy Education Session

August 30, Washington, DC Washington, DC Dear Chairman Cochran, Chairman Blunt, Vice Chairman Leahy and Ranking Member Murray:

Implementing the 2017 President s Challenge: Primary, Secondary & Tertiary Prevention of Addiction & Substance Misuse

Welcome to AIDSWatch March 27 th and 28 th, 2017

Targeted Outreach & Other Strategies for Increasing HCV Testing

Eliminating Viral Hepatitis in Australia: Where are we in 2017?

On behalf of the Infectious Diseases Society of America (IDSA), I offer testimony in

Revisiting Oral Health Advocacy:

The Affordable Care Act and HIV: What are the Implications?

0VS -FHJTMBUJWF 3FHVMBUPSZ 3FBDI

The Affordable Care Act and HIV/AIDS: Implications for Coverage, Access to Care, and Payment

#2015USCA

Responding to HIV/AIDS in Illinois Remarks to the Adequate Health Care Task Force

HHS Priorities and Actions to Support Treatment for Those with Opioid Use Disorder

The Affordable Care ACT (ACA) Association of State and Territorial Dental Directors Webinar Wednesday, November 20, 2013

An Unhealthy Truth: Rising Rates of Chronic Disease and the Future of Health in America

Health Care Reform: Implications for Public Health. Susan Polan, PhD. American University Next steps in Health Reform 2017

High Impact Prevention for People Who Inject Drugs. June 30, 2015

Advancing the National HIV/AIDS Strategy: Housing and the HCCI. Housing Summit Los Angeles, CA

Florida HIV/AIDS Advocacy Network (FHAAN)

A Place at the Table: Having a Voice in HIV Planning and Decision Making Last updated: January 14, 2019

2. What type of general services does your organization provide? Please check all that apply.

REPORT OF THE COUNCIL ON SCIENCE AND PUBLIC HEALTH. AMA Policy Consolidation: Influenza and Influenza Vaccine

Submitted to the House Energy and Commerce Committee. Federal Efforts to Combat the Opioid Crisis

Ms. Tramaine Stevenson Director of Program Development and Operations National Council for Behavioral Health

Oral Presentation to the H.E.L.P. Committee on February 14, 2012 Philip A. Pizzo, MD

CDC s Response to the Viral Hepatitis/Opioid Syndemic

LeadingAge and Hospice Members: Partners in Providing Quality Care to Older Adults. January 2019

Increasing PrEP Awareness and Knowledge in Your Jurisdiction

New Mexico HCV Elimination

Hispanics/Latinos and Hepatitis: An Overlooked Health Disparity. National Hispanic Hepatitis Awareness Day

Proposed Maternal and Child Health Funding Highlights Fiscal Year 2013 Senate Labor, Health and Human Services Appropriations

Advocating for Syringe Exchange Programs

HIV Prevention Action Coalition

American Diabetes Association 2017 Advocacy Priorities LaShawn McIver, MD, MPH Friday, February 17, :30 p.m. 5:15 p.m.

The National Association of State Alcohol and Drug Abuse Directors (NASADAD) FY 2018 Appropriations

Collective Impact Report

DISCOVER THE BENEFITS OF MEMBERSHIP

EXTEND THE INVITATION: A 10 STEP APPROACH TO INTERNAL ORGANIZING

Transcription:

Ending the HIV Epidemic: The Role of Provider Advocacy Melanie Thompson, MD Chair, HIVMA Steering Committee Member, RWMPC Title Slide Michelle Ogle, MD Board Member, HIVMA Steering Committee Member, RWMPC Moderator: Andrea Weddle, Executive Director, HIVMA ACTHIV April 5, 2018

Who We Are HIVMA represents diversity of HIV health care providers and promote quality care by advocating for policies that ensure a comprehensive and humane response to the AIDS pandemic. Represent more than 6,000 HIV health care providers and researchers. Sponsors the Ryan White Medical Providers Coalition Nested within the Infectious Diseases Society of America 2

Advocating for People with HIV & Providers 2018 Priorities Health care access & coverage Medicaid, Marketplace coverage, fair drug pricing Federal funding for CDC, HRSA s Ryan White, NIH, Global Health Evidenced-based prevention syringe exchange, safe consumption sites, comprehensive sex ed Reducing stigma and discrimination Addressing social determinants of health 3

Recent Wins Averted Repeal of the Affordable Care Act (2017) Congress rejected the President s 2018 budget Sustained funding for the Ryan White Program Increased NIH funding by $3 billion Increased CDC funding for Viral Hepatitis by $5 million and STD $5 million Increased HOPWA funding by $19 million Maintained funding for the Minority AIDS Initiative Increased funding for the opioid response by $3.3 billion 4

Call to Action: ID & the Opioid Epidemic Heightened prevention Enhanced epi and surveillance data Build health care provider capacity Expand access to HIV, HCV & other ID treatment & to addiction treatment Research & support for models to co-treat addiction & infections 5

Responding to the STD Epidemic Engaging with CDC Promoting STD screening & treatment Addressing barriers to treatment Increasing provider awareness & education 6

Ryan White Medical Providers Coalition Inaugural Meeting August 2006 Created by HIVMA to give providers a voice in Ryan White program and policy discussions Membership free to Ryan White medical providers and program administrators Stay up-to-date on Ryan White policy updates and advocacy opportunities Join us at our annual luncheon at IDWeek

RWMPC Advocacy RWMPC builds strong relationships with policy makers: Meets with Congressional offices Submits Congressional testimony Participates in Congressional briefings Hosts clinic visits for Congress and Administration Meets with key Administration leaders Serves as direct line of communication to providers

HOW TO GET INVOLVED 9

Is Effective Advocacy Possible Now? YES! August 2006 Don t be distracted by the noise & chaos Effective education & advocacy principles remain the same learn them & stay the course! Adapting to the new environment means: Building new relationships Using arguments and techniques persuasive to your audience

Advocacy Challenges & Opportunities Health care and funding issues have been urgent all year Party affiliations don t always equal policy position Some issue campaigns take years to accomplish: Think long-term Marshall data Don t give up!

HIV Medical Providers Are Effective Advocates Viewed as responsible Knowledgeable and expert Affiliated with important community institutions hospitals, universities, health centers Can simplify complex issues akin to patient education Know a lot of people, so are influential

Taking Action Call your Congressional Representatives Respond to advocacy alerts Use social media to engage with policymakers Organize meetings with your Congressional members or their staff in their district offices Submit op-eds or letters to the editor to your local paper Invite Congressional members to visit your clinics (202) 224-3121 13

The Power of Clinic Visits Show and tell powerfully communicates the outcomes and effectiveness of comprehensive HIV treatment Clinic visits are a good advocacy tool because they provide that opportunity to show and tell Visits to my Ryan White clinic in rural Henderson, NC demonstrate the clinic s and patients successes and challenges RWMPC can help you plan an effective clinic visit!

Hot Topics Provider Voices Needed State Medicaid Waivers Weigh in on requests to impose work requirements and other enrollment barriers Opioid Epidemic Educate policymakers on the effectiveness of syringe exchange 340B Program Share how 340B helps your clinic or hospital support HIV prevention and care HIV Criminalization Laws Join efforts to reform state laws and policies 15

HIVMA & RWMPC -- Here to Help How to webinars, fact sheets, talking points & more www.hivma.org www.hivma/rwpworks 16

OPEN FORUM 17

Contact Us, Follow Us and Get Involved Melanie Thompson, MD Chair, HIVMA drmt@mindspring.com Michelle Ogle, MD Board Member, HIVMA mdenise.ogle@gmail.com @hivma @drmt http://cqrcengage.com/idsociety/ Andrea Weddle Executive Director, HIVMA aweddle@hivma.org 18